Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 90,122 | 92,055 | 101,907 | 152,915 | 114,617 |
| Cost of Goods | 33,768 | 21,635 | 24,897 | 19,477 | 21,374 |
| Gross Profit | 56,354 | 70,420 | 77,010 | 133,438 | 93,243 |
| Operating Expenses | 320,806 | 447,221 | 524,010 | 559,026 | 533,652 |
| Operating Income | -263,684 | -376,166 | -446,103 | -425,111 | -440,035 |
| Interest Expense | 25,334 | 28,911 | 47,313 | 37,118 | 46,354 |
| Other Income | 12,762 | 40,094 | -29,864 | 18,282 | 46,335 |
| Pre-tax Income | -276,256 | -364,983 | -523,280 | -443,947 | -440,054 |
| Income Tax | -200 | 3,215 | 557 | 493 | 613 |
| Net Income Continuous | -276,056 | -368,198 | -523,837 | -444,440 | -440,667 |
| Net Income | $-276,056 | $-368,198 | $-523,837 | $-444,440 | $-440,667 |
| EPS Basic Total Ops | -1.45 | -1.97 | -2.86 | -2.49 | -2.52 |
| EPS Basic Continuous Ops | -1.45 | -1.97 | -2.86 | -2.49 | -2.52 |
| EPS Diluted Total Ops | -1.45 | -1.97 | -2.86 | -2.49 | -2.52 |
| EPS Diluted Continuous Ops | -1.45 | -1.97 | -2.86 | -2.49 | -2.52 |
| EPS Diluted Before Non-Recurring Items | -0.86 | -1.97 | -2.86 | -2.24 | -2.52 |
| EBITDA(a) | $-179,368 | $-363,136 | $-431,957 | $-410,929 | $-438,273 |